In MR, blood flows backwards through the mitral valve into the atrium with ... in May 2024 for treating MR and mitral annular ...

Led by Boston Scientific, the funding will expedite the clinical development and commercialisation of 4C Medical’s ...

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical ... the addition of moderate and severe mitral annular calcification.

Primary mitral regurgitation results from actual disease of the mitral valve apparatus. The mitral valve leaflets, annulus, papillary muscles and chordae tendinae must interact properly for the ...

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Functional mitral valve regurgitation occurs when the left atrium or left ventricle dilates, causing the mitral valve annulus to also dilate and prevent the mitral valve leaflets from properly ...

C Medical Technologies has closed its Series D financing round, raising gross proceeds of up to $175m. Led by Boston ...